![William Shakespeare](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Shakespeare
Nessuna posizione attualmente
Storia della carriera di William Shakespeare
Precedenti posizioni note di William Shakespeare
Società | Posizione | Inizio | Fine |
---|---|---|---|
THESEUS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/06/2018 | 01/05/2021 |
Direttore Tecnico/Scientifico/R&S | 01/05/2018 | 09/11/2023 | |
Fondatore | 29/12/2017 | 09/11/2023 | |
ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 29/07/2009 | 01/01/2017 |
Astra AB
![]() Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Corporate Officer/Principal | - | - |
Formazione di William Shakespeare
Gettysburg College | Undergraduate Degree |
University of New Hampshire | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Svezia | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
ARIAD Pharmaceuticals, Inc.
![]() ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Astra AB
![]() Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
Theseus Pharmaceuticals, Inc.
![]() Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- William Shakespeare
- Esperienza